The US Food and Drug Administration has approved a vaccine against respiratory syncytial virus (RSV), an illness that kills thousands of Americans each year. The vaccine still needs approval from the US Centers for Disease Control and Prevention before it can be rolled out to the public. Officials say the vaccine, named Arexvy by the manufacturer GSK, is a major breakthrough that will save many lives.
You May Also Like
Two-day pharma and healthcare expo kickstarts
Lahore: Pak Pharma and Healthcare expo in collaboration with the Pakistan Pharmaceutical…
- Alina Hashmi
- February 16, 2023
Punjab changes admission policy for medical, dental colleges
The Punjab education authorities have changed the admission policy for the government…
- Hafsa Mustafa
- October 2, 2023
Trio wins Nobel Chemistry Prize for quantum dots
French-born Moungi Bawendi, Louis Brus of the United States and Russian-born Alexei…
- Hafsa Mustafa
- October 4, 2023
US, Hungarian scientists win Nobel for research on Covid vaccines
Scientists Katalin Kariko of Hungary and Drew Weissman of the United States…
- Hafsa Mustafa
- October 2, 2023